×

Healthcare

USD Analytics healthcare data solutions deliver information, analytics, and solutions for the world's major medical device, pharmaceutical companies, financial markets, and governments. The company leverages its vast databases and industry expertise to present in-depth and up-to-date analyses of healthcare industries. The solution enables users to make efficient and informed decisions across the market. The Global Healthcare markets service presents an analysis of 60 countries with an updated outlook for the pharmaceutical industry. The reports in the service are updated every month and present healthcare expenditure, pharmaceutical sales, pharmaceutical goods trade balance, population forecasts, life expectancy, Consumer Price Inflation, GDP forecast, regulatory analysis, and company profiles. The Pipeline, Epidemiology, and Disease Market Outlook service presents disease pipeline reviews, clinical trial analysis, epidemiology reports, and disease market outlook for over 300 conditions. In addition, Analysis of marketed drugs, upcoming drug candidates, and other information is included in the research solutions. Further, the market size outlook and competitive analysis of medical devices, Healthcare IT, Analytics and Instrumentation, and the Biotechnology industry outlook are analyzed.

Healthcare
Chemical Report Listings

Migraine Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Treatment (Acute Treatment, Preventive Treatment), By Therapeutic Class (Triptans, Acetylcholine Inhibitors/ neurotoxins, Ergot Alkaloids, NSAIDs, Ditans, CGRP Small molecule antagonists, CGRP monoclonal antibodies, Others), By Route of Administration (Oral, Injectables, Others), Countries and Companies Report

Migraine Drugs Market is projected to register a 7.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00021327  |   No. of Pages: 187

Oral Cancer Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Targeted Therapy, Chemotherapy), By End-User (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Stores), Countries and Companies Report

Oral Cancer Therapeutics Market is projected to register a 5.7% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022614  |   No. of Pages: 203

Intrauterine Devices Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Hormonal IUD, Copper IUD), By Distribution Channel (Hospital, Gynecology Clinics, Community Health Care Centers, Others), Countries and Companies Report

Global Intrauterine Devices Market Size is valued at $4.9 Billion in 2024 and is forecast to register a growth rate (CAGR) of 3.9% to reach $6.7 Billion by 2032.

Published On: November, 2024  |   Report Code: USD00028760  |   No. of Pages: 185

Pediatric ENT Market Size, Share, Trends, Growth Outlook, and Opportunities to 2032- By Product (Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids, Hearing Implants, Nasal Splints), Countries and Companies Report

Global Pediatric ENT Market Size is valued at $8.2 Billion in 2024 and is forecast to register a growth rate (CAGR) of 5.6% to reach $12.7 Billion by 2032.

Published On: November, 2024  |   Report Code: USD00031375  |   No. of Pages: 210

Intrauterine Contraceptive Devices (IUD) Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Hormonal Intrauterine Device, Copper Intrauterine Device), By End-User (Hospitals, Gynecology Clinics, Community Health Care Centers), Countries and Companies Report

Intrauterine Contraceptive Devices (IUD) Market is projected to register a 4.7% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022376  |   No. of Pages: 190

3D Vascular Ultrasound Imaging Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Application (Vascular Imaging, Fetal Cardiac, Gynecology, Ophthalmology, Others), Countries and Companies Report

3D Vascular Ultrasound Imaging Market is projected to register a 4.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00021699  |   No. of Pages: 190

Transcatheter Aortic Valve Replacement Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Implantation Procedure (Transfemoral, Transapical, Transaortic), By Material (Stainless Steel, Nitinol, Cobalt Chromium, Others), By Mechanism (Balloon-expanding Valve, Self-expanding Valve), By End-user (Hospitals, Ambulatory Surgical Centers, Others), Countries and Companies Report

Transcatheter Aortic Valve Replacement Market is projected to register a 9.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00021615  |   No. of Pages: 191

Veterinary Telehealth Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Animal Type (Canine, Feline, Equine, Bovine, Swine, Others), By Service (Telemedicine, Teleconsulting, Telemonitoring, Others), Countries and Companies Report

Veterinary Telehealth Market is projected to register a 17.6% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00021665  |   No. of Pages: 202

Non Hodgkin Lymphoma Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Therapy (Chemotherapy, Radiation Therapy, Targeted Therapy, Others), By Cell Type (B-cell Lymphomas, T-cell Lymphoma), Countries and Companies Report

Non Hodgkin Lymphoma Therapeutics Market is projected to register a 7.7% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00012025  |   No. of Pages: 191